Why the study?
Does long-term beta-adrenergic blockade reduce the transcapillary escape rate of albumin in patients with essential hypertension?
Does long-term beta-adrenergic blockade reduce the transcapillary escape rate of albumin in patients with essential hypertension?
Answers are grounded in this paper and cite their sources.
Long-term beta-blocker therapy in essential hypertension normalizes the abnormally high transcapillary escape rate of albumin, correlating with blood pressure reduction.
Treatment of 10 patients with essential hypertension was found to reduce significantly the abnormally high transcapillary escape rate of albumin (fraction of intravascular albumin mass that passes to the extravascular space per unit time) from 7.1 to 5.7 per cent/hour (normal value 5.6 ± S.D. 1.1). The albumin outflux (amount of intravascular albumin that passes to the extra-vascular space per unit time) decreased from 8.7 to 6.8 g/hour. This was found by determining the disappearance of intravenously injected 131I-human serum albumin during the first 60 minutes after i.v. injection before and after 3 to 4 months of beta-adrenergic blocking treatment that practically normalized the blood pressure (mean 171/116 → 144/98 mm Hg). The decrease in transcapillary escape rate correlated significantly with the reduction in blood pressure. Plasma volume was not affected by treatment.
No takes yet. Share an insight, caveat, or question.
Parving et al. (1973) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: